The unit-based dosing information for semaglutide helps you track exactly how many doses remain in your pen before you travel
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse
Developed by Eli Lilly, this medication targets not one but two key hormone pathways (GIP and GLP-1) that regulate blood sugar, appetite, and fat metabolism
Contact a clinician if symptoms are severe, persistent, or associated with reduced urination, dizziness, or inability to keep fluids down
Compounding Regulatory Landscape: According to the FDA, litigation challenging the semaglutide shortage resolution is ongoing
Staying in close communication with your PlexusDx provider during this window allows for dose modifications or symptom-management strategies tailored to your response pattern, ensuring you don't abandon an otherwise effective therapy prematurely